Cisapride does not modify prolonged Q-T interval in patients with liver cirrhosis;La cisaprida no altera el intervalo Q-T prolongado en pacientes con cirrosis hepática

Revista Medica de Chile

Volumn 128, Issue 8, 2000, Pages 847-852

  Quera P, Rodrigo ^a   Madrid S, Ana María ^a   Ugalde P, Héctor ^a   Defilippi C, Carlos ^a  

^a HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

Cirrhosis; Cisapride; QT interval

Indexed keywords

CISAPRIDE; GASTROINTESTINAL AGENT;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; DRUG EFFECT; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HOSPITALIZATION; HUMAN; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; SYSTOLE; TIME;

ADULT; AGED; ANALYSIS OF VARIANCE; CISAPRIDE; ELECTROCARDIOGRAPHY; FEMALE; GASTROINTESTINAL AGENTS; HEART RATE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SYSTOLE; TIME FACTORS;

EID: 0034242364     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. BRAUNWALD E. Heart Disease, Ed. W.B Sanders Company Fourth Edition 1992; 122.
2. MOSS A. Measurement of the Q-T interval and the risk associated with Q-Tc interval prolongation: A review. Am J Cardiol, 1993; 72: 23B-25B.
3. ZIMETBAUM P, JOSEPHSON M. Risk factors for and diagnosis of the long Q-T syndrome and torsade de Pointers. UpDate 7.3.1999.
4. FRANCIS G. Cardiac Complications in the intensive care unit Clinics in Chest Medicine, 1999; 20; 2: 269-85.
5. ZAREBA W, MOSS A, LE CESSIE S, LOCATI E, ROBINSON J, HALL W ET AL. Risk of cardiac events in family members of patients with long Q-T syndrome. J Am Coll Cardiol, 1995; 26: 1685-91.
6. DAY C, JAMES O, BUTLER T, CAMPBELL R. Q-T prolongation and sudden cardiac death in patients with alcoholic liver disease. Lancet, 1993; 341: 1423-8.
7. BERNANDI M, CALANDRA S, COLANTONI A, TREVISANI F, RAIMONDO M, SICA G ET AL. Q-T interval prolongation in cirrhosis. prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors. Hepatology, 1998; 27: 28-34.
8. CHESTA J, DEFILIPPI CL, DEFILIPPI C. Abnormalities in proximal small bowel motility in patients with liver cirrhosis. Hepatology, 1993; 17: 828-32.
9. MADRID A, CUMSILLE F, DEFILIPPI C. Altered small bowel motility in partients with liver cirrhosis depends on severity of liver disease. Dig Dis Sci, 1997; 42: 738-42.
10. MADRID A, DEFILIPPI C. Efecto de la cisaprida en la motilidad intestinal de la cirrosis hepática. Gastr Latinoam, 1995; 6: 285.
11. MADRID A, HURTADO C, VENEGAS M, QUERA R, VALENZUELA J, DEFILIPPI C. Tratamiento a largo plazo con cisaprida oral en pacientes con cirrosis hepática. Gastr Latinoam, 1998; 9: 285.
12. LEVINE A, FOGELMAN R, SIROTA L, ZANGEN Z, SHAMIR R, DINARI G. Q-T interval in children and infants receiving cisapride. Pediatrics, 1998; 101: 1-3.
13. OLSSON S, EDWARS I. Tachycardia during cisapride treatment. BMJ, 1992; 305: 748-9.
14. WYSOWSKI D, BACSANYI J. Cisapride and fatal arrythmia. N Engl J Med, 1996; 335: 290-1.
15. CHRISTENSE E, SCHLICHTING P, FAUERTHOLDT L, GLU C, ANDERSEN PK, JUHL E ET AL. Prognostic value of Child-Turcotte criteria in medically treated cirrhosis. Hepatology, 1984; 3: 430-5.
16. LAFFI G, LAGI A, CIPRIANI M, BARLETTA G, BERNARDI L, FATTORINI L ET AL. Impaired cardiovascular autonomic response to passive tilting in cirrhosis with ascitis. Hepatology, 1996; 24: 1063-7.
17. KEMPLER P, VARADI A, SZALAY F. Autonomie neuropathy and prolongation of QT-interval in liver disease. Lancet, 1992; 340: 318.
18. MOHAMED R, FORSEY P, DAVIES M, NEUBERGER J. Effect of liver transplantion on Q-T interval prolongation and autonomie dysfunction in end stage liver disease. Hepatology, 1996; 23: 1128-34.
19. TREVISANI F, SICA G, MAINQUA P, CARACENI P, COLANTONI A, DE NOTARUS S ET AL. Normalization of prolonged Q-T interval after liver transplantation in cirrhosis. Hepatology, 1996; 24: 179.
20. LEHMANN M. QT prolongation in end-stage liver disease: a result of altered sex hormone metabolism?. Hepatology, 1997; 26: 244.
21. DRICI M, BURKLOW T, HARIDASSE V, GLAZER R, WOOSLEY R, ET AL. Sex hormones prolong the QT interval and downregulate potasium channel expression in the rabbit heart. Circulation, 1996; 94: 1471-4.
22. DROLET B, KHALIFA M, DALEAU P, HAMELIN B, TUKGEON J. Block of the rapid component of the delayed rectifer potassium current by the prokinetic agent Cisapride underlies drug-related lengthening of the QT interval. Circulation, 1998; 97: 204-10.
23. HENNEY J. Revised Labeling for Cisapride. JAMA, 2000; 283: 1131.
24. MADRID A, DEFILIPPI C, HURTADO C, VENEGAS M, GOTTELAND M, VALENZUELA J. El tratamiento prolongado con antibióticos y prokinéticos mejora la motilidad intestinal, sobrecrecimiento bacteriano e insuficiencia hepática en pacientes con cirrosis hepática. Gastr Latinoam, 1999; 4: 325.